'Contribution of component' and the perioperative immune-checkpoint inhibitor precedent
Nat Rev Clin Oncol
.
2024 Apr;21(4):249-250.
doi: 10.1038/s41571-023-00857-9.
Authors
Garth W Strohbehn
1
2
3
,
Bishal Gyawali
4
Affiliations
1
Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI, USA. gstrohbe@umich.edu.
2
Rogel Cancer Center, Michigan Medicine, Ann Arbor, MI, USA. gstrohbe@umich.edu.
3
Institute for Health Policy and Innovation, University of Michigan, Ann Arbor, MI, USA. gstrohbe@umich.edu.
4
Department of Oncology, Division of Cancer Care and Epidemiology, Queen's University, Kingston, Ontario, Canada.
PMID:
38182900
DOI:
10.1038/s41571-023-00857-9
No abstract available
MeSH terms
Humans
Immune Checkpoint Inhibitors*
Substances
Immune Checkpoint Inhibitors